These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 35413266)
21. Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter. Sahl JW; Gillece JD; Schupp JM; Waddell VG; Driebe EM; Engelthaler DM; Keim P PLoS One; 2013; 8(1):e54287. PubMed ID: 23365658 [TBL] [Abstract][Full Text] [Related]
22. Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii. Nwugo CC; Arivett BA; Zimbler DL; Gaddy JA; Richards AM; Actis LA PLoS One; 2012; 7(12):e51936. PubMed ID: 23284824 [TBL] [Abstract][Full Text] [Related]
23. Identification of two hydrophilins that contribute to the desiccation and freezing tolerance of yeast (Saccharomyces cerevisiae) cells. Dang NX; Hincha DK Cryobiology; 2011 Jun; 62(3):188-93. PubMed ID: 21420397 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. Wang N; Ozer EA; Mandel MJ; Hauser AR mBio; 2014 Jun; 5(3):e01163-14. PubMed ID: 24895306 [TBL] [Abstract][Full Text] [Related]
25. Chemical shift assignments and secondary structure prediction of the C-terminal domain of the response regulator BfmR from Acinetobacter baumannii. Olson AL; Thompson RJ; Melander C; Cavanagh J Biomol NMR Assign; 2014 Apr; 8(1):67-70. PubMed ID: 23264007 [TBL] [Abstract][Full Text] [Related]
26. Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Runci F; Gentile V; Frangipani E; Rampioni G; Leoni L; Lucidi M; Visaggio D; Harris G; Chen W; Stahl J; Averhoff B; Visca P Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718286 [No Abstract] [Full Text] [Related]
28. 2-Hydroxylation of Bartholomew TL; Kidd TJ; Sá Pessoa J; Conde Álvarez R; Bengoechea JA Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30745327 [No Abstract] [Full Text] [Related]
29. Involvement of HisF in the Persistence of Martínez-Guitián M; Vázquez-Ucha JC; Álvarez-Fraga L; Conde-Pérez K; Lasarte-Monterrubio C; Vallejo JA; Bou G; Poza M; Beceiro A Front Cell Infect Microbiol; 2019; 9():310. PubMed ID: 31555607 [No Abstract] [Full Text] [Related]
31. Genomic and functional analysis of the type VI secretion system in Acinetobacter. Weber BS; Miyata ST; Iwashkiw JA; Mortensen BL; Skaar EP; Pukatzki S; Feldman MF PLoS One; 2013; 8(1):e55142. PubMed ID: 23365692 [TBL] [Abstract][Full Text] [Related]
32. Acinetobacter: an emerging pathogen with a versatile secretome. Elhosseiny NM; Attia AS Emerg Microbes Infect; 2018 Mar; 7(1):33. PubMed ID: 29559620 [TBL] [Abstract][Full Text] [Related]
33. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
34. Acinetobacter baumannii biofilm biomass mediates tolerance to cold plasma. Flynn PB; Graham WG; Gilmore BF Lett Appl Microbiol; 2019 Apr; 68(4):344-349. PubMed ID: 30706947 [TBL] [Abstract][Full Text] [Related]
35. Coping with low water activities and osmotic stress in Acinetobacter baumannii: significance, current status and perspectives. Zeidler S; Müller V Environ Microbiol; 2019 Jul; 21(7):2212-2230. PubMed ID: 30773801 [TBL] [Abstract][Full Text] [Related]
37. Pilus Production in Acinetobacter baumannii Is Growth Phase Dependent and Essential for Natural Transformation. Vesel N; Blokesch M J Bacteriol; 2021 Mar; 203(8):. PubMed ID: 33495250 [No Abstract] [Full Text] [Related]
38. Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Hood MI; Jacobs AC; Sayood K; Dunman PM; Skaar EP Antimicrob Agents Chemother; 2010 Mar; 54(3):1029-41. PubMed ID: 20028819 [TBL] [Abstract][Full Text] [Related]
39. AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments. Jacobs AC; Thompson MG; Black CC; Kessler JL; Clark LP; McQueary CN; Gancz HY; Corey BW; Moon JK; Si Y; Owen MT; Hallock JD; Kwak YI; Summers A; Li CZ; Rasko DA; Penwell WF; Honnold CL; Wise MC; Waterman PE; Lesho EP; Stewart RL; Actis LA; Palys TJ; Craft DW; Zurawski DV mBio; 2014 May; 5(3):e01076-14. PubMed ID: 24865555 [TBL] [Abstract][Full Text] [Related]
40. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Greene C; Vadlamudi G; Newton D; Foxman B; Xi C Am J Infect Control; 2016 May; 44(5):e65-71. PubMed ID: 26851196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]